SCHEMBL8697964

SCHEMBL8697964

COC(=O)NN=CN1CCC(c2cc(C)cc(OS(=O)(=O)c3ccccc3Cl)c2OC)CC1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.41
F2 P00734 12/20 0.38
PRSS2 P07478 5/20 0.37
F10 P00742 2/20 0.37
CTRC Q99895 5/20 0.37
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
DRD2 P14416 1/20 0.35
ADRA1D P25100 1/20 0.35
ADRA1A P35348 1/20 0.35
ADRA1B P35368 1/20 0.35
FAAH O00519 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8697603 0.88 HTR6 (0.45) HTR6F2PRSS2F10CTRC
SCHEMBL8697954 0.82 F2 (0.39) HTR6F2PRSS2F10CTRC
Hydrochloric Acid SCHEMBL8696200 0.81 F2 (0.41) HTR6F2PRSS2F10CTRC
SCHEMBL8697958 0.81 F2 (0.46) HTR6F2PRSS2F10CTRC
SCHEMBL8694486 0.81 F2 (0.46) HTR6F2PRSS2F10CTRC
SCHEMBL8696210 0.80 STS (0.45) HTR6F2PRSS2F10LMNA
SCHEMBL8697599 0.80 F2 (0.58) HTR6F2PRSS2F10CTRC
SCHEMBL8698423 0.80 F2 (0.39) HTR6F2PRSS2F10CTRC
SCHEMBL8695388 0.79 F2 (0.44) HTR6F2PRSS2F10CTRC
SCHEMBL8696257 0.79 F2 (0.44) HTR6F2PRSS2F10CTRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5792769-A POTENT ANTICOAGULANT, ANTIINFLAMMATORY AGENT; TREATMENT/PROPHYLAXIS OF RESPIRATORY SYSTEM DISORDERS, VASCULAR SYSTEM DISORDERS, ANTITUMOR AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-08-11 US claimed
US-5792769-A POTENT ANTICOAGULANT, ANTIINFLAMMATORY AGENT; TREATMENT/PROPHYLAXIS OF RESPIRATORY SYSTEM DISORDERS, VASCULAR SYSTEM DISORDERS, ANTITUMOR AGENTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 1998-08-11 US disclosed